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Abstract
Autosomal recessive spastic paraplegia 52 is caused by biallelic mutations in
AP4S1 which encodes a subunit of the adaptor protein complex 4 (AP-4).
Using next-generation sequencing, we identified three novel unrelated SPG52
patients from a cohort of patients with cerebral palsy. The discovered variants
in AP4S1 lead to reduced AP-4 complex formation in patient-derived fibrob-
lasts. To further understand the role of AP4S1 in neuronal development and
homeostasis, we engineered the first zebrafish model of AP-4 deficiency using
morpholino-mediated knockdown of ap4s1. In this model, we discovered sev-
eral phenotypes mimicking SPG52, including altered CNS development, loco-
motor deficits, and abnormal neuronal excitability.
Introduction
The hereditary spastic paraplegias (HSP) are a group of
rare and genetically heterogeneous neurodegenerative dis-
orders characterized by progressive spasticity.1,2 Autoso-
mal recessive spastic paraplegia-52 (SPG52) is a form of
childhood-onset complex hereditary spastic paraplegia
characterized by early developmental delay, microcephaly,
epilepsy, and progressive spasticity. Given the slowly pro-
gressive nature of this disease, patients are often
diagnosed with cerebral palsy (CP) before genetic testing
is pursued. SPG52 is caused by bi-allelic loss-of-function
variants in AP4S1, which encodes the sigma subunit of
the adaptor protein complex 4 (AP-4), and has been
described in less than 10 individuals, thus far.3 AP-4 role
in endosome membrane trafficking was evaluated in a
previous study.4
Here we screened a large cohort of patients with a
diagnosis of CP for mutations in genes related to HSP
and identified three novel unrelated individuals with
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SPG52. To gain further insights into the role of mutant
AP4S1 in neuronal development and function, we devel-
oped the first model of AP-4 deficiency in zebrafish
(Danio rerio) using morpholino-mediated knockdown of
ap4s1, which recapitulate the main aspects of the patients’
phenotype.
Materials and Methods
All participants, including relatives involved in the segre-
gation studies, provided written informed consent in
accordance with the Italian National Health Service
guidelines and the Declaration of Helsinki. Ethics com-
mittee approval was available. Animal experiments were
performed in accordance with the IACUC at the Univer-
sity of Pisa. Inclusion criteria were a clinical diagnosis of
CP5 and accurate recording of at least one neurologic
examination and brain MRI. Variants in AP4S1
(ENST00000216366.8) were detected using a targeted
next-generation sequencing (NGS) panel approach
designed to cover reported HSP and spastic ataxia genes2
or, in 5 cases, using whole exome sequencing. Variants
were confirmed by Sanger sequencing. Pathogenicity was
scored in silico using CADD.6 Fibroblasts were derived
via diagnostic punch biopsies. However, qPCR, RT-PCR
and Western blotting were carried out using published
protocols. Adult male and female zebrafish AB and
Tg (Neurod1-GcAMP6f) were maintained according to
standard procedures.7 Morpholino antisense oligonu-
cleotides (MO) targeting transcription at the exon 3
acceptor splice site or ATG start codon and a standard
scramble MO8 were designed as reported in Data S1.
Touch-evoked escape response was measured at 48 hpf
on a semi-quantitative scale ranging from severe (=no
movement), to mild (=flicker of movement but no swim-
ming), or normal (=normal swimming).9 Coiling fre-
quency was evaluated at 30 hpf using the Leica M205FA
microscope (Leica, Wetzlar, Germany) and Danio Scope
software (Noldus, Wageningen, The Netherlands). Behav-
ioral and movement data were acquired using Danio
Vision at 120 hpf and analyzed using EthoVision software
(Noldus). The transgenic NeuroD1 line was used to assess
brain/head morphology after MO injection at 72 hpf.
Electrophysiological forebrain recordings were performed
at 120 hpf. Statistical analyses used GraphPad Prism v.7.1
with significance set at P < 0.05.
Results
Through NGS studies of 112 individuals with a clinical
diagnosis of CP, we identified three children harboring
biallelic variants in AP4S1. These variants are predicted to
cause an early truncation of the protein (Fig. S1A) and
segregate in the families (Fig. S2). Clinical, molecular and
neuroimaging findings are in Table 1. All three patients
presented with developmental delay and later intellectual
disability as well as slowly progressive spasticity. Patient
#3 required a wheelchair at the age of 9 years, whereas
patients #1 and #2 are still ambulant (with aid) at age 18
and 4 years, respectively. Epilepsy was found in all three
cases: patient #1 developed focal seizures at age
10 months; patient #2 had epileptic spasms at 14 months,
and patient #3 experienced generalized seizures starting at
12 months. In all three cases, seizures were well con-
trolled with standard antiepileptic drugs. Fibroblasts from
patients #1 and #2 (Fig. 1A and B) showed reduced levels
of AP4E1, consistent with the notion that a loss of the
sigma subunit of AP-4 destabilizes the protein complex
leading to reduced levels of other AP-4 subunits. More-
over, levels of ATG9A, the major cargo of AP-4, were sig-
nificantly increased consistent with prior reports.10
Zebrafish ap4s1 shares 78% identity with the human gene
and protein (Fig. S1C). In situ hybridization analysis
(WISH) confirmed that ap4s1 mRNA is ubiquitously
expressed in 48 hpf embryos and 72 hpf larvae, with a
high expression in the CNS (Fig. S1D). However, at ear-
lier stages, WISH and qPCR demonstrated ap4s1 mRNA
expression mainly after 24 hpf (Fig. S1E and F). To
knock-down gene expression, we designed two different
MOs, ATG- and splice-MO; after testing both, we noticed
a stronger effect using the splice-MO, whereas the ATG-
MO induced a milder yet significant phenotype as com-
pared to uninjected fish (Fig. S1G). MO-mediated knock-
down of ap4s1 (Fig. S1H and I) lead to several
morphological defects including decreased head size, ven-
triculomegaly, altered eye development, cardiac edema,
and a curved tail (Fig. 1C and D). Whilst Ap4e1 protein
levels were reduced (Fig. 1E), we could not study ATG9A
because commercial antibodies failed to recognize the fish
protein (not shown).
Moreover, behavioral analysis revealed that at 30 hpf
ap4s1 morphant embryos showed an increased coiling fre-
quency compared to uninjected ones (Fig. 1F; Videos S1
and S2). Touch evoked response was impaired in over
80% of injected morphants at 48 hpf (Fig. 1G). Rescue
experiments were performed through co-injection of
200 pg of either human WT or zebrafish mRNA together
with spliceMO at the same concentration used for the
knockdown experiments (Fig. 1G). At 120 hpf ap4s1-defi-
cient zebrafish larvae showed locomotor impairment
(Fig. 1H and I). To further explore the nature of this
motor deficit, we investigated the morphology of spinal
motor neurons using the motor axon marker Znp1.
Immunolabeling of spinal motor neuron axons in 48 hpf
morphants and control embryos showed abnormal axon
outgrowth and a reduction in axon length (Fig. 1J).
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Staining of acetylated a-tubulin confirmed truncated
axons that appeared thinner than in controls and were
hardly visible in the most severely affected embryos
(Fig. 1K). Knockdown of ap4s1 resulted in not only an
alteration of ventrally projecting motor neurons at 48 hpf
but also a strong reduction in axon distribution in the
anterior region of the CNS. To further characterize the
neurodevelopmental consequences of ap4s1 depletion, we
studied the pan-neural marker Sox3 and the postmitotic
neuronal marker Huc/Hud (Fig. 1K). Morphants (24 hpf)
showed a reduction in Sox3 staining suggesting an
impairment in the maintenance of the neuronal progeni-
tor pool (Fig. 1K). Huc/Hud staining was globally
reduced indicating loss of postmitotic neurons, in partic-
ular at the level of diencephalon, telencephalon and in
the optic tectum (Fig. 1K). Overall, these results suggested
an impairment of primary neurogenesis in ap4s1 zebrafish
morphants. This corroborates the altered CNS morphol-
ogy observed in 72 hpf ap4s1-depleted Neurod1-GFP
embryos (Fig. 1D). To further explore the functional
implications of loss of ap4s1, we measured local field
potentials in the forebrain of control and ap4s1-depleted
embryos at 120 hpf. We detected no difference at room
temperature (23°C) (Fig. 1L). When the temperature was
raised to 33°C, frequent bursts were observed in ap4s1
morphant larvae (Fig. 1L), indicating a lower threshold
for abnormal excitability in the setting of stressors, mim-
icking in part what is experienced by SPG52 children.5
Discussion
We here describe three additional cases of SPG52 discov-
ered by genetic screening of a cohort of patients with a
diagnosis of CP. Clinical and imaging features of these
patients resemble those reported previously.3,5,11–14 Inter-
estingly, patient #1 presented with a relatively mild phe-
notype and preserved independent walking at the age of
18 years. On a cellular level, fibroblasts derived from two
patients showed reduced levels of the AP4E1 subunit con-
sistent with reduced stability of the AP-4 complex. In line
with prior reports,10 we also observed an accumulation of
ATG9A, further corroborating the pathogenicity of the
discovered SPG52 variants. In humans, AP4S1 encodes a
protein whose function is, only in part, understood, also
because of the absence of in vivo models of SPG52,
though initial iPSC studies15 appear helpful to study axon
outgrowth. To explore the consequence of loss of AP4S1
in vivo, we generated the first zebrafish model of AP-4-
deficiency. Antisense morpholino-mediated knockdown of
ap4s1 resulted in a robust reduction in expression. Loss
of formation of a functional AP-4 complex was confirmed
by a reduction in protein levels of the Ap4e1 subunit, a
surrogate for complex formation,10 a finding already seen
in SPG52 disease. Various neurodevelopmental brain mal-
formations are found in patients with AP-4-associated
hereditary spastic paraplegia (SPG47, SPG50, SPG51, and
SPG52).3 These include a thinning of the corpus
Table 1. Clinical features of three patients with SPG52.
Patient Patient #1 Patient #2 Patient #3
Sex Female Female Male
AP4S1 Variant1 c.47insT/c.234insG p.Ser17*/
p.Ala79Glyfs*4
c.234insG/c.234insG p.Ala79Glyfs*4/
p.Ala79Glyfs*4
c.138 + 2T>G/c.138 + 2T>G
CADD Score 28.9/28.1 28.1 25.9
Age at last evaluation 18 years 4 years, 10 months 14 years
Consanguinity No Yes Unknown
Ethnicity Caucasian Caucasian Caucasian
Spasticity Spastic tetraplegia Spastic tetraplegia Spastic tetraplegia
Level of ambulation Walks without support Walks with support Wheelchair-dependent
Developmental Delay/
Intellectual Disability
Severe Severe Moderate
Speech Simple sentences Nonverbal Nonverbal
Short Statue Yes Yes No
Microcephaly Yes (postnatal) Yes (postnatal) No
Thin Corpus Callosum Yes Yes Yes
Ventriculomegaly No No Yes
Cerebral Atrophy Yes No No
Cerebellar Atrophy Yes No No
Seizures Focal (onset at 10 years) Epileptic spasms (onset at 14 months) Focal and generalized (onset at
12 months)
EEG Sharp waves on bilateral anterior
regions
Generalized sharp waves Diffuse epileptiform
abnormalities
1AP4S1 Reference Sequence ENST00000313566.
586 ª 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Loss of ap4s1 in Zebrafish Resembles SPG52 A. D’Amore et al.
ª 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 587
A. D’Amore et al. Loss of ap4s1 in Zebrafish Resembles SPG52
callosum, loss of periventricular white matter with result-
ing ventriculomegaly, as well as polymicrogyria in some.
In ap4s1-depleted zebrafish, we observed a reduction in
head size and a complex CNS malformation. In combina-
tion with the finding of reduced staining for neuronal
progenitors and postmitotic neurons, these results
demonstrate the crucial role of AP-4 for neuronal devel-
opment. Mimicking the human phenotype, we found
locomotor deficits in ap4s1-depleted zebrafish. Behavioral
assays in morphant larvae revealed significant defects
inverall mobility, suggesting that ap4s1-related motor
neuron development and function is required for normal
motility in zebrafish. We next examined spinal motor
axons and found that morphants exhibited shorter axonal
length, indicating that SPG52 may be important for the
outgrowth of motor axons. This is consistent with
impaired neuron outgrowth found in cultured neurons
from Ap4e1 knockout mice16,17 and similar to results seen
in several zebrafish models of HSP including spastin,18
atl1,19 and spatacsin.20 Seizures are found in about two-
thirds of AP-4-HSP patients and febrile seizures are com-
mon early in life.3 Local field potentials recordings of
forebrain in ap4s1-depleted zebrafish revealed no sponta-
neous seizures at basal temperature. With hyperthermia,
however, burst of abnormal activity were induced, sug-
gesting the possibility for a lower threshold for epilepti-
form activity in the setting of stressors.
Summarizing, ap4s1 knockdown in zebrafish leads to
several phenotypes that resemble AP4S1-associated heredi-
tary spastic paraplegia. Thus, this first zebrafish model of
AP-4 deficiency represents a new tool for dissecting the
role of AP-4 in neurodevelopment and neurodegeneration
and could be the starter point for future drug screening,
along with a KO model.
Acknowledgments
The authors sincerely thank the patients and their families
for their help and willingness to participate in this study.
We also thank Professor Margaret Robinson (Cambridge,
UK) for donating AP4E1 antibody. This work was sup-
ported by the University of Siena “Pegaso Scholarship” (to
AD), the Italian Ministry of Health, Ricerca 5x1000 (to
FMS, RB, and FS), the Italian Ministry of Health, grant
#RC2017-2018-2019 (to MTB), and funds from CureSPG47
Inc., the Spastic Paraplegia Foundation (SPF) Inc., the
Thrasher Foundation and the Lovejoy Award (all to DEF).
Conflict of Interest
Ebrahimi-Fakhari reports grants from Thrasher Research
Fund, grants from Spastic Paraplegia Foundation, grants
from CureSPG47 Foundation, during the conduct of the
study. All other authors declare no conflict of interest
related to this study.
Author Contribution
Conception and design of the study: A.D., F.G., F.M.S.
Acquisition and analysis of data: A.D., A.T., V.N., G.F.,
D.G., M.M., S.M., G.B., A.C., M.T.B., F.S., J.B., R.R.,
R.B., I.R., A.R., and D.E.F. Drafting a significant portion
of the manuscript or figures: A.D., J.H., M.M., D.E.F,
M.S., and F.M.S.
Figure 1. (A and B) Western blot analysis from whole cell lysates of patient #1 and patient #2 as well as two healthy, unrelated controls. Levels
of AP4E1 are reduced, consistent with the notion that loss of AP4S1 destabilizes the AP-4 complex and lowers levels of the other subunits.
ATG9A, the main cargo of AP-4, is increased in fibroblasts from patient #1 and patient #2, consistent with prior reports. This indicates a loss of
AP-4 function (one-way ANOVA with multiple comparison, n = 2–6 samples per condition per experiment, P-value: ****<0.0001; ***0.0002;
**0.0008). (C) Morphology of zebrafish embryos injected with MOap4s1 at 48 hpf. Mild and severe phenotypes are found. Several dysmorphic
features are present, including an abnormal eye shape, smaller head size, cardiac edema and curved tail. (D) CNS morphology as assessed by GFP
fluorescence in NeuroD1-GFP zebrafish at 72 hpf. Dotted line outlines head area (ROI). GFP-fluorescence within the ROI is significantly reduced
(Mann–Whitney test, n = 10; P-value: **0.0052). (E) Western blot analysis from lysates of ap4s1-depleted zebrafish at 72 hpf shows reduced
Ap4e1 expression (unpaired t-test, n = 2; P-value: ***0.0004). (F) Coiling frequency in zebrafish embryos at 30 hpf is increased in ap4s1-depleted
zebrafish (Mann–Whitney test, n = 80 in 4 independent experiments; P-value: ***0.0002). (G) Touch-evoked escape response was measured at
48 hpf on a semi-quantitative scale ranging from severe (=no movement), to mild (=flicker of movement but no swimming), or normal (=normal
swimming). About 80% of ap4s1-depleted zebrafish show a mild or severe impairment and about 40% of morphants showed partial rescued
phenotypes, after co-injection with either human or zebrafish mRNA (Chi Square Test, n = >100 in 2 independent experiments; P value:
****<0.0001). (H and I) Automated analysis of spontaneous motor activity revealed a reduction in swim distance and velocity in ap4s1-depleted
zebrafish at 120 hpf (Mann–Whitney test, n = 37 per condition; P-value: ****=<0.0001; **=0.0011). (J) Immunocytochemistry with motor neuron
marker znp1 demonstrates a reduction in axon length of spinal motor neurons in ap4s1-depleted zebrafish at 48 hpf (Mann-Whitney test,
n = 20; P-value: ****=<0.0001). (K) Immunocytochemistry using the pan-neural marker sox3 and the postmitotic neuronal marker Huc/Hud in
24 hpf embryos. A reduction in sox3 staining, suggesting an impairment in the maintenance of the neuronal progenitor pool, is found in ap4s1-
depleted zebrafish. Huc/Hud staining was globally reduced in ap4s1-depleted zebrafish indicating loss of postmitotic neurons, in particular at the
level of diencephalon, telencephalon and in the optic tectum. (L) Local field potentials recorded from 120 hpf zebrafish. At an ambient
temperature of 23°C there was no difference observed. When the temperature was raised to 33°C frequent bursts were found in ap4s1-depleted
zebrafish, indicating abnormal excitability and a lower threshold for epileptiform activity in the setting of stressors.
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Figure S1. (A) Three-dimensional model of human
AP4S1 (qmean4 global score: 0.710).
Figure S2. Family tree and segregation of mutations in
the kindred. Circles and squares are women and men,
respectively. Filled symbols are affected individuals.
Data S1. Additional methods.
Video S1. Coiling frequency in uninjected zebrafish
embryos at 30 hpf.
Video S2. Coiling frequency in zebrafish embryos injected
withMOap4s1 at 30 hpf.
ª 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 589
A. D’Amore et al. Loss of ap4s1 in Zebrafish Resembles SPG52
